SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " SIR " 934 found 🔀 AI-powered Shuffle
Philadelphia 76ers Delivered Good News On LeBron James’ Top 3
One week into NBA free agency, LeBron James could be narrowing down his desired destination to three teams. The Philadelphia 76ers recently received good news on that front. According to the ESPN NBA insider Shams Charania, the Sixers appear to be in James’ top three at this stage of the process (which could change). The […] The post Philadelphia 76ers Delivered Good News On LeBron James’ Top 3 appeared first on HEAVY.
Small Business Spotlight: Business blooms beyond bouquets
BUSINESS: The Busy Bloom OWNERS: Amanda and Walter Adkins ADDRESS: 708 S. 17th St., Wilmington EMAIL: thebusybloomco@gmail.com WEBSITE: thebusybloomco.com PHONE NUMBER: (910) 742-0790 YEAR FOUNDED: 2024 NO. OF EMPLOYEES: 4 WHAT IS THE BUSY BLOOM? AMANDA ADKINS: “The Busy Bloom is a flower shop with a spin – a creative experience shop located in Wilmington’s Cargo District. Founded in 2024 by husband-and-wife team Amanda and Walter Adkins, we offer fresh flowers, botanical teas, a build-your-own bouquet bar, candle-making experiences, gifts, workshops, wedding florals and event services. Our mission is simple: to make flowers accessible, approachable and enjoyable for everyone – not just for special occasions.” WHY DID YOU START THE BUSINESS? AMANDA ADKINS: “The Busy Bloom was born from a lifelong connection to flowers and a desire to create meaningful experiences for people. After doing my own wedding florals and after years of working in healthcare management, I found myself returning to gardening and floral design as a creative outlet and source of healing. The loss of my mother-in-law, who always shared flowers from her garden, inspired me to pursue floristry full-time. My husband encouraged me and built a small flower cart for us to grow, and fast forward to now, two years later, it has grown into a community-centered business focused on bringing joy, connection and creativity through flowers.” WHAT KIND OF GROWTH ARE YOU HOPING FOR? AMANDA ADKINS: “We’re focused on sustainable growth that allows us to continue serving our community while expanding creative experiences. We hope to grow our wedding and event services, expand our educational workshops and creative programming and become a destination where people can gather, create and connect. We’re also passionate about creating opportunities that showcase floral design as an art form, such as our Fleur Couture fashion show and other community collaborations.” WHAT PAST EXPERIENCE HAVE YOU HAD WITH STARTING/WORKING IN BUSINESS? AMANDA ADKINS: “Before opening The Busy Bloom, I worked as a clinical manager in healthcare and spent years building leadership, operations and customer service skills. I’ve also worked in education and nonprofit programming, teaching people about nature and local ecosystems. Along the way, I designed flowers for weddings and events on the side, gradually turning a passion into a business. Walter has years of welding and construction experience, combined with entrepreneurship and a drive to own his own company. …The Busy Bloom has been a journey of combining creativity with entrepreneurship alongside my husband ... learning every step of the way.”
Siri AI can pull info from third-party apps in the latest developer beta
We’ve been looking out for new features in iOS 27 beta 3, and we’ve now found an additional one: the...
Everything New in iOS 27 Beta 3
Apple is continuing to refine iOS 27 ahead of its planned September launch, and the third beta includes several new features. Siri is more customizable, there's a fun new wallpaper action, and some useful improvements to Photos and Shortcuts. Siri Voice Beta 3 adds support for Siri voice customization on compatible devices. The customization option existed in prior betas, but it was not active.
Apple adds new popup for AI features that send data to Google Cloud
Apple now uses Google servers to power some of its new and upcoming AI features, and the company is using...
You can now customize Siri's pace and expressivity in the latest iOS 27 beta
The new controls let you control how quickly Siri speaks and expressive its voice is.
Apple Seeds Third iOS 27 and iPadOS 27 Betas to Developers
Apple today seeded the third betas of iOS 27 and iPadOS 27 to developers for testing purposes, with the update coming two weeks after Apple released the second betas. Registered developers can download the betas from the Settings app on the iPhone or iPad by going to the General section and selecting Software Update. iOS 27 introduces Apple's smarter version of Siri, Siri AI.
Senegal's Faye Plans to Form His Own Political Party
DAKAR, July 6 (Reuters) - Senegal's President Bassirou Diomaye Faye is planning to set up his own political party, a coalition supporting him said, the latest evidence of a durable split with his recently ousted prime minister. • Faye has instructed senior adviser Aminata Toure to establish ...
The Sports Audio Report: Demographics at Play
Younger Sports Fans Are More Likely to Engage with Sports Audio Download the Report >> Millennial and Gen Z sports fans spend more time with sports audio weekly than Gen X and Boomers, according to the Sports Audio Report: Demographics at Play from Edison Research and SiriusXM Media. Millennial sports fans spent an average of 6 hours and 16 minutes with...
Former Trail Blazers Forward Trendon Watford Teases Portland Return
With Portland’s frontcourt depth thin after a blockbuster backcourt overhaul, a versatile former fan favorite signals his desire to bring size and playmaking back to Rip City.
Strasbourg, Nice and Lyon pursuing Allsvenskan’s top scorer Robbie Ure
RC Strasbourg Alsace, OGC Nice and Olympique Lyonnais are reportedly keeping a close eye on the situation regarding IK Sirius’ Robbie Ure (22), according to L’Équipe.Currently the top scorer in t...
'She's Special': Harper’s Corner Wire-To-Wire Winner Of Schuylerville
Charles Bigg’s Harper’s Corner made every pole a winning one in Friday’s $200,000 Schuylerville (L), a six-furlong sprint for 2-year-old fillies on opening day at Saratoga Race Course. Trained by Cathal Lynch and piloted by Paco Lopez, the dark bay who became the first stakes winner for her sire, ...
Jimmy Butler believes he’ll return better than ever
Jimmy Butler is confident his comeback from ACL surgery will be a successful one. The Warriors star says he expects to return as one of the NBA’s top players while revealing his desire to finish his Hall of Fame-caliber career in Golden State.
HOMETOWN HEALTH: Health reminders for the Fourth of July holiday weekend
As millions prepare to celebrate the Fourth of July, health officials are urging the public to take precautions
NHS to reward people who walk 30 minutes a day
The "marathon a month" scheme, developed with former Olympic medallist Sir Brendan Foster, will launch early next year.
Morgan Fairchild has one word to describe Hollywood legend Elizabeth Taylor
Morgan Fairchild was brief when describing her interactions with the Oscar-winning Hollywood legend Elizabeth Taylor, with whom she worked in a 1980s miniseries.
F.B.I. Assigns Scores of Analysts to Examine Election Records in Georgia
The expansion of an investigation into Fulton County’s election office reflects President Trump’s desire to prove his baseless claims that the 2020 election in Georgia was rigged.
iOS 27 makes a very strong case for upgrading to a new iPhone
Most years, major iOS updates offer the same basic feature set on new iPhones and old ones. But with iOS...
Sports Audio Report: Female Fans
The latest report, Sports Audio Report: Female Fans with Edison Research, SiriusXM Media, and GroupM explores the unique audio listening habits of U.S. female sports fans and shows how they interact with sports beyond the field. Sports audio plays an integral role in female sports fandom – 57% of female sports fans “frequently” or “occasionally” listened to sports audio content in...
Federal Reserve Chair Warsh emphasizes political independence
When asked about President Trump’s oft-repeated desire for lower rates at a central bank conference, Warsh underscored the Fed’s independence from day-to-day politics.
New Federal Reserve Chair Warsh emphasizes political independence, signals focus on inflation
New Federal Reserve Chair Kevin Warsh said Wednesday that the central bank would remain independent and seek to bring down inflation, likely foreclosing the rate cuts President Donald Trump has sought. The Fed typically combats inflation by raising borrowing costs. When asked about Trump's oft-repeated desire for lower rates, Warsh underscored the Fed's independence from day-to-day politics.
Ways and Means in early stages of tackling sports taxation
Republican and Democratic tax writers are interested in changing how collegiate and professional athletics are handled in the tax code — but they’re in the early stages of discussing what those changes might look like. Members of the House Ways and Means Committee during a nearly four-hour hearing Tuesday expressed a desire to come to […]
Two Dan Sullivans will be on the ballot in Alaska
The incumbent senator accuses his challenger of being a Democratic plant set up to confuse primary voters, but fellow Republican Dan J. Sullivan has said his desire to run is genuine.
Elliot Page shows off insane abs in shirtless boxing photos and video
'The Odyssey' star Elliot Page says he's 'hooked' on boxing and shows off his ripped abs.
Liverpool transfer news: Bradley Barcola among alternative targets with PSG in talks to sign Yan Diomande
Liverpool target Yan Diomande has indicated his desire to join Paris Saint-Germain; PSG winger Bradley Barcola features highly among options Reds are considering as an alternative; Barcolas PSG future is uncertain due to frustrations about being overlooked for selection in big games
It’s Linux, On A Sega Megadrive
If you were in the market for a games console in 1990, the chances are that the object of your desire was either a Super Nintendo with its 16-bit 6502 derivative, or the Sega Megadrive, sold as the…
The last, best hope for the Colorado GOP
If the Colorado Republican Party desires to retain any relevancy, let alone wrest back any of the levers of political control in the state, it needs to elect Barb Kirkmeyer in the June 30 primary. To be sure, Kirkmeyer would be a solid candidate for governor in any case, whether or not she shared the […]
Jalen Brunson gets a standing ovation at Mariska Hargitay's play after announcing his 'SVU' dream
Jalen Brunson received a standing ovation at Mariska Hargitay's Broadway play 'Every Brilliant Thing.' The New York Knicks star previously stated his desire to guest star on 'Law & Order: SVU.'
Meet A Retriever—Manikanta Sirumalla, International Data Science Graduate Student And Entrepreneur - UMBC: University Of Maryland, Baltimore County
If you want help meeting a big new fitness goal, Manikanta Sirumalla may have the app for you. Manikanta came to UMBC from India as a graduate student
Sephora CEO Guillaume Motte on Creating Demand and Scaling Desire
The beauty retailer’s chief executive spoke at day two of The Business of Beauty Global Forum about the strategies that have led to $5 billion in growth over the past three years.
Making Our Own Luck
We are cross-posting a piece that former NIH official Kris Willis wrote for Macroscience. Kris is now the President and Founder of the Woodley Park Institute, for which I’m a board member. Picking winners or hedging bets? Federal science agencies have long wrestled with the question of how to ensure their billions of dollars of grants and contracts result in maximum benefits for Americans. On the surface, it might seem that a goal-oriented, interventionist style of management would be the best policy: prioritize our most pressing problems and distribute funding accordingly.This top-down strategy creates a unique hazard, though: bad choices can send resources in the wrong direction, resulting in slow progress that impedes the delivery of tangible benefits to citizens. Moreover, if decision makers pursue an applied advance when the underlying scientific principles remain poorly understood, they risk costly failures and a loss of support for the research enterprise at large. Examples include Nixon’s 1971 War on Cancer, undertaken on the premise that a cure could be achieved in less than a decade, the drive to build an operational commercial fusion plant by the mid-1990s, and the National Plan to Address Alzheimer’s Disease, which failed to produce the effective treatments and prevention strategies promised by 2025. The contrasting laissez-faire approach is to hedge your bets. If the path to an advance is impossible to predict, then the wisest choice might be to distribute funding to as widely as possible. The main risk of this strategy is that spreading funding thinly may limit the resources available to the most promising research, resulting in the same negative outcomes as the interventionist approach: limited support for the most promising topics, slow progress, and delayed returns. In reality, at science agencies like the National Science Foundation and National Institutes of Health, program managers navigate between these two extremes, setting some funds aside to target high-priority areas and using the rest to cover the widest possible range of meritorious proposals. This middle path seems like the most rational way to proceed, but it still requires making choices. How much should be set aside for high priority topics? What should those topics be? How should we define merit? Expert opinion can provide a helpful guide, but leading experts can have remarkably different opinions about what matters and what should be prioritized. Moreover, experts and administrators alike can be risk averse, giving an edge to high-profile, well-established concepts. What’s really needed is a data-driven framework to help guide decision-making, one that doesn’t simply repackage prestige or incumbency. Recognizing breakthroughs years in advance Many breakthroughs fail to attract funding or recognition at the earliest stages of development. Katalin Karikó, for example, spent years struggling to win grants for work on mRNA that would eventually win her and Drew Weissman a Nobel Prize. Similar stories can be told about Jim Allison’s groundbreaking studies leading to the development of cancer immunotherapy, Stan Pruisner’s demonstration that prions can self-replicate without DNA, or Robin Warren and Barry Marshall’s proof that Helicobacter pylori, not stress, causes ulcers. Yet at some point, the scientific community recognizes and responds to transformative breakthroughs like these. How does that change happen? And what if science funders could identify the areas that are on the cusp of a breakthrough? Those questions led my collaborators and me to study how scientists responded to past breakthroughs. Based on patterns in that data, we developed a means of predicting future breakthroughs, using biomedicine as a proof of concept. It’s worth taking a moment to describe how our approach works. Briefly, our prediction process begins by grouping the 18 million or so peer-reviewed papers in PubMed, the authoritative database of biomedical research, into roughly 50,000 unique topics. A small subset of these topics are so widely acclaimed as breakthroughs that they have been recognized with a major prize like a Nobel or a Lasker Award. We theorized that studying the development of these outliers over time, especially before they gained acclaim, was the key to identifying future instances of them. After defining topics, we chose 21 representative breakthroughs and asked what they looked like before they won prestigious prizes. To answer that question, we re-ran our topic-mapping algorithm repeatedly, winding back the clock one year each time, stringing together the years to follow the progress of each field as it grew and advanced. We found that in each case, the years leading up to a discovery followed a pattern: a burst of papers on a new, rapidly evolving topic, many of which quickly became influential. These characteristics—the percent of papers that are new, the percentage of papers that are brought in from other topics, and the influence of each individual paper—can all be measured separately for any given topic. Together, they act as a predictive signal that is detectable an average of five years before a transformative discovery is made, and up to thirty years before the discovery receives a major prize. Scanning the current research landscape for topics that display this signal allows us to predict what work will likely produce a future breakthrough. Each year we analyzed includes four or five signals, a number that appears to have remained constant across a twenty year time frame. In their classic work on the sociology of science, Bruno Latour and Steve Woolgar established that the desire to participate in a major discovery is an important motivator for scientists as they consider whether they should take up (or abandon) a research problem. Although further work is needed, the simplest explanation for our results is that this behavior is widespread enough to detect at scale. A foundational advance, or something like it, draws the attention of scientists and causes them to change the direction of their research. They vote with their feet, staking their own reputation and careers by publishing on and citing the new idea. That upswell of interest is the foundation of our breakthrough signal. What kind of research does our model identify as a breakthrough? After building a model based on the patterns in our 21 preselected breakthroughs, we tested it by identifying all early signals of discovery from 1994 through 1997. Of the 18 signals we found in that time period, 17 can be traced forward in time to a breakthrough. Examples include super-resolution fluorescence microscopy (see the image above), the directed evolution of proteins and enzymes (Chemistry Nobel, 2018), and sequencing the human genome (National Medal of Science, 2008). The discovery of the role of leptin signaling in obesity is a particularly interesting case study. Around 1950, scientists noticed the existence of a type of lab mouse that suffered from a unique inherited form of obesity. When given the freedom to choose their own diet, these mice ate more than normal and preferred food that was high in fat. Researchers had few clues as to why the animals overate; early experiments pointed to the existence of a soluble ob factor found circulating in the bloodstream that regulated appetite, but its identity was unknown. In 1994, Jeffrey Friedman and colleagues identified and sequenced the ob gene, noting that the protein it encoded appeared to fit the profile of a circulating factor. A year later, a trio of high-profile publications demonstrated that ob was a hormone that regulated body weight and fat deposition by regulating appetite. One of these was co-authored by Friedman, who christened it leptin from the ancient Greek word for thin. Using our model, the data from 1996 make it clear this advance would become a breakthrough. Scientists had flocked to study the biology of the new hormone, generating the flurry of new papers and citations required to produce a signal. One of these demonstrated that serum leptin concentrations reflected the amount of adipose tissue in the human body, providing clinical validation of the earlier mouse studies. Before the identification of leptin, scientists were unable to point to a specific molecule that controlled appetite and adiposity, so that it was impossible to rule out non-physiological causes of obesity; its characterization fundamentally changed our concept of weight gain. In 2010, Friedman and fellow pioneer Douglas Coleman were awarded a Lasker for the discovery. Our work also identifies breakthroughs in clinical practice and behavioral and social sciences, even though these areas are less likely to draw the attention of major prize committees. One example that falls into this category is the introduction of endovascular aneurysm repair, a minimally invasive surgical procedure for the treatment of abdominal aortic aneurysm, a leading cause of death among Americans over the age of 65. Relative to the previous standard of care, it reduces in-hospital mortality by almost four-fold. In 2017, Timothy Chuter received the American College of Surgeons’ prestigious Jacobsen Innovation award for his multiple refinements to the technique. Another under-recognized breakthrough identified by our model is the development of standardized survey instruments to assess the quality of life for HIV+ patients. The antiretroviral cocktails introduced in the mid-1990s reduced AIDS mortality, but treatment came with serious side effects. The new evaluations showed that patients whose disease progressed had worse physical functioning than Americans with other chronic diseases, while those who were asymptomatic maintained a health-related quality of life on par with the overall US population. This evidence made it possible for patients and activists to argue that even in the absence of a total cure, and in spite of the side effects, alleviation of symptoms was a worthwhile priority for clinicians. My colleagues and I have failed to identify any significant recognition for the physicians and health policy experts who pioneered this advance, although in 2016, researchers called for the World Health Organization to set targets for good health-related quality of life as part of its framework to end the AIDS pandemic. From forecasting to funding How should science funders use our predictions? Any serious discussion of what we should do with this new capability needs to begin with an understanding of its limitations. We can’t (and shouldn’t) invest all of our resources in the small number of topics predicted to produce breakthroughs. Innovative new fields are born from existing ones; they rarely arise de novo. If funders don’t maintain a diverse portfolio, the breakthroughs of tomorrow will have no antecedents. Think of this as eating the seed corn, or killing the goose that lays the golden egg. There are also multiple goals of funding beyond basic scientific discovery, including translating discoveries into clinical practice, developing new technologies, supporting economic development, and training new scientists. The investments needed to accomplish these goals are likely different from those required to support emerging breakthroughs. Finally, we must be aware that we may not capture every instance of a breakthrough. The concept is fuzzy, and not every significant discovery is recognized with a major award. Further, breakthroughs are rare, meaning that our dataset is, by necessity, small. This makes formal estimates of accuracy challenging. Although our overall success rate appears to be high, any one signal may turn out to be a false positive. We found one apparent example: the development of the third generation COX-2 inhibitors, Vioxx and Celebrex, which were much celebrated in the early 2000s as effective but non-addictive pain relievers, meets all the algorithmic criteria of a breakthrough. Five years after it received FDA approval, researchers demonstrated that Vioxx was associated with serious cardiovascular complications, and the manufacturer voluntarily pulled the drug from the market. Celebrex remains available, although like other NSAIDs, it carries an FDA warning for increased cardiovascular risk. Decision makers who were overly focused on the breakthrough potential of this research might have wasted substantial resources nurturing an area that ultimately proved to be a failure—but so would those who relied on expert opinion at the time. That said, the potential benefits of funding the next mRNA vaccine or cancer immunotherapy years earlier than we might have are large. When we can’t assume the outcome of an action, it’s worth conducting an experiment. Can targeted support for areas that are poised to produce a breakthrough increase the return on scientific investment without cannibalizing future advances? With the necessary administrative infrastructure in place, conducting this experiment would be straightforward. First, identify all the breakthrough signals between 2018 and 2023, select half at random, and commit to a decade of investment. For biomedicine, a six year window should yield about 30 topics with the potential to produce a breakthrough. Providing strong support to half of these might be accomplished for $300 million a year. That’s roughly half of the recent annual budget of the NIH Common Fund or around 20% of the fiscal year 2025 budget for ARPA-H. After five years, then again at ten, compare to see which group — the one that was actively managed, or the control — produced more breakthroughs, and on what timescale. Although we used biomedicine as an example, the same experiment could just as well be run for physics, materials science, or any other discipline. Any attempt to undertake such an experiment should keep three points top of mind. First, we can predict the topic of future breakthroughs, but the people and vision for how to move the work forward are still important. In practice, this means success requires active program managers with the expertise to develop the science and the authority to do so, including by recruiting investigators. Second, we would be wise to learn from the failures of past attempts to fund transformative research. High among these are funding modestly repackaged work, confusing the genuinely novel with the merely unfamiliar, and relying too much on incumbent investigators. All of these risks can be mitigated by thoroughly and intelligently integrating high quality data into portfolio management. Finally, we need to have patience. Even with strong funding support, producing a breakthrough takes time. If supporting breakthroughs is the best way to nurture the birth of new fields, we also need to accurately describe and properly manage the other two stages, so that we invest wisely throughout the productive lifetime of ideas and divest once they reach the point of diminishing returns. We would benefit from more study of all of these phases, especially the transition from one to another. More research could answer questions like: When does a breakthrough become an established field? How do the availability of funding, the size and characteristics of the available workforce, and the accumulation of evidence that disagrees with prevailing models affect a field’s decline? Exactly how do old ideas give birth to new ones, and can we speed up the process? The more we understand about the dynamics of scientific progress, the better we can maximize the odds that our curiosity leads to results. I’d call that finding a way to make our own luck.
NASA Selects Rocket Lab to Launch Sun, Earth Science Missions
NASA has selected Rocket Lab to provide the launch service for both the agency’s PolSIR (Polarized Submillimeter Ice-cloud Radiometer) and Total and Spectral Solar Irradiance Sensor-2 (TSIS-2) missions.
David P. O'Brien
About five years ago, David P. O'Brien had a comfortable position at Marsh & McLennan Cos., where he held the top post at the financial giant's Louisville, Ky., office. Despite the lofty rank, Mr. O'Brien found himself longing to be at a smaller company that had to work a little harder to land business. That desire led him away from Kentucky five years ago and to Cleveland, where he serves as executive vice president at business insurance agency Oswald Cos. "I left Marsh before it was en vogue," he said, referring to layoffs and defections at Marsh over the course of this year that followed accusations of bid rigging at the big firm. Above all, Mr. O'Brien, 38, wanted to work at a company that relied on its inventiveness, rather than its name, for business. He said he has found that at Oswald. "It causes you to be more creative, to be more resourceful," Mr. O'Brien said. For instance, an Oswald client seeking to do business internationally might be directed to the network of offices abroad run by competitors such as Marsh and Aon Risk Services Inc. "We're going to use whatever access into the market that makes the most sense for our clients," he said. Of course, using such a strategy can be dangerous for Oswald if its client decides to further a business relationship with one of the firms Oswald recommended. "That's the obvious question and why it's nontraditional," he said. "I think if we're good, and if we're bringing value to the client, then there's no risk. I'm not threatened by it." Imaginative business solutions of that type made his career move to Oswald from Marsh worthwhile. "It's very much a challenge," he said. "It helps you keep your edge. I'm all for the competition." John Jacunski, currently vice president and corporate controller at York, Pa., paper company PH Gladfelter Co., met Mr. O'Brien four years ago when Mr. Jacunski was at WCI Steel Inc. in Warren. So impressed was he with Mr. O'Brien's work for WCI that Mr. Jacunski has retained the Oswald executive at PH Gladfelter. "He's a young guy for the position he has, but he's done a great job for us," Mr. Jacunski said. Among his roles at Oswald, Mr. O'Brien leads the firm's client retention efforts and also serves as director of its property and casualty group. "You don't have the same human resources," he said of the job jump to Oswald. "You don't have, obviously, the safety net a big company has." But sometimes, it can be difficult to ascertain individual contributions when working at a big company. "I wanted to be able to see the end results of my work and my efforts," Mr. O'Brien said.
KFF Poll Shows Three in Ten Adults Turn to Social Media or AI for Health Information, with Lower-Income Adults More Likely to Cite Cost and Access Barriers as a Reason
The latest KFF Tracking Poll on Health Information and Trust finds roughly three in ten adults report turning to social media (31%) or AI chatbots (29%) at least monthly for health information and advice. The top reasons people report turning to social media for health advice are wanting to hear from those with similar experiences or a desire for quick information.
Apple tells Siri AI to clearly refuse requests to summarize URLs
A new rule added to Siri AI’s system prompt in iOS 27 beta 2 changes how it should handle requests involving extracting or summarizing content behind a URL.
Bringing the Lab into the Classroom with NYC’s Youngest Scientists
The Scientist-in-Residence Student Showcase is a culminating celebration of science education.
Science Philanthropy in a Democracy Under Pressure
Lessons from Brazil on how science philanthropy can and should act in the face of political hostility.
Science Decoupling Hurts Human Progress
Science magazine has reported that in May, several members of the U.S. Congress introduced the Securing Innovation and Research from Adversaries (SIRA) Act, a bill that would prohibit U.S. researchers from using federal funds to collaborate with 'blacklisted' Chinese entities. These include Chinese institutions and individuals. Joint research projects, co-authored papers, data sharing, personnel exchanges, and even the co-supervision of students would all be prohibited.
Bunnie Xo Was ‘Seriously Considering a Return’ to Adult Entertainment Before Jelly Roll Split
Jelly Roll and Bunnie Xo‘s divorce news made headlines earlier this month, and a new report says that her desire to return to the world of adult entertainment played a part in their decision to part w...
Andy Burnham to get briefings on taking over as prime minister
Sir Keir Starmer is offering "access talks" with the civil service to Labour leadership candidates.
Everything New in iOS 27 Beta 2
Apple released the second beta of iOS 27 today, and as is common with a second beta, there are multiple changes. There are new features and updates to existing features as Apple prepares for a July public beta and a September software launch. Write with Siri There is a new Write with Siri button above the keyboard in Notes, Mail, Messages, and more. It makes it easier to locate the option to use Siri for writing. In the first beta, the Write with Siri tool was only available when selecting text.
iOS 27 beta 2 includes Write with Siri, the new version of Apple Intelligence writing tools
iOS 27 beta 2 includes our first look at the new Write with Siri features, which replace the standalone Writings...
Apple Seeds iOS 27 and iPadOS 27 Second Betas to Developers
Apple today seeded the second betas of iOS 27 and iPadOS 27 to developers for testing purposes, with the update coming a week after Apple released the first betas following the WWDC 2026 keynote. Registered developers can download the betas from the Settings app on the iPhone or iPad by going to the General section and selecting Software Update. iOS 27 introduces Apple's smarter version of Siri, Siri AI.
Beyond Siri: Here are the practical AI features coming to your iPhone in iOS 27
Siri’s AI overhaul may have grabbed the headlines at WWDC, but some of Apple’s most useful AI features are arriving elsewhere in iOS 27.
Gordon Monson: To my father, and all the fathers out there
Tribune columnist Gordon Monson reflects on his father’s impact 25 years after his death.
Apple Unveiled These Five New Apps Last Week
Apple last week unveiled five new apps, with four announced at WWDC 2026 alongside its upcoming fall software updates, one released in beta for developers, and one released independently by its subsidiary Claris. Siri AI App One of the biggest announcements of WWDC 2026 was Siri AI, a ground-up rebuild of Apple's voice assistant that for the first time comes with a dedicated standalone app.
Every new iOS 27 feature that's worth knowing about
While it's not flashy like Apple’s new Siri AI and Apple Intelligence upgrades, there are still a number of additions to iOS 27 worth looking at.
Siri AI Hands On: A Smart, Helpful Assistant
The new Siri AI is conversational, omnipresent, and actually helpful.
Analysing the Trionda: The science behind the 2026 World Cup ball
How the history of soccer has been shaped by panels, grooves and a desire to avoid wobbliness
Teti identified as Milan’s latest option for sporting director
Milan’s hunt for a senior management team continues and the latest reports claim that Domenico Teti is the latest name under consideration for the role of sporting director in San Siro.Teti the late...
Apple just said the thing about Siri that we’ve long wanted to hear
One key Siri AI upgrade is that it’s the same Siri everywhere, regardless of device—which Apple says was a very intentional goal.
Joanna Stern spent one week with new Siri AI, and it’s very good
Joanna Stern spent a week testing iOS 27’s new Siri AI in a variety of ways, and her new video shares how it went.
Apple Explains Why watchOS 27 Drops Support for So Many Models
Apple today detailed why five Apple Watch models will miss out on watchOS 27 and the new Siri AI features that come with it. The Apple Watch Series 6, 7, 8, SE 2, and the original Apple Watch Ultra will not receive watchOS 27, and will only get basic security updates going forward. With the update, Apple is effectively dropping three years' worth of device support in a single software update, which is unprecedented for the product line.
iPhone 18 Pro and Pro Max: smaller Dynamic Island, new camera, and 4 more upgrades could come at a higher price
A next-gen 2nm A20 Pro chip, brand-new Siri AI features, and fresh colorways could headline this September’s release.
Now two powerful NC politicians say Raleigh would be a good MLB expansion city
MLB in NC has been a topic for years. Now the governor and Senate leader say Raleigh is a desirable location for a team.
Known Agenda Sold To Stand In Uruguay
Known Agenda, a Grade 1 winner and young sire, has been sold to continue his stud career at Haras La Peregrina in Maldonado, Uruguay, BloodHorse reports. The 8-year-old son of Curlin leaves Spendthrift Farm in Kentucky, where he began his stud career in 2022. Known Agenda's first foals are ...
Sweet treats stir up sweet memories at downtown Doniphan business
Within these walls, bright, cheery colors, the smells of warm chocolate and caramel, and the sounds of laughter welcome both the young and young at heart who
iPadOS 27 Hands-On: Everything New for iPad
Like iOS 27, iPadOS 27 gains a smarter, more capable version of Siri, the Siri app, and new Apple Intelligence features in apps, but there are a few iPad-only standouts. Subscribe to the MacRumors YouTube channel for more videos. Siri AI on iPad has all of the same features as Siri AI on the iPhone, so it can access your personal data, search the web for answers, complete tasks in apps, and answer questions about what's on your screen.
Trump defends his Iran deal, criticizes longtime ally Israel as G-7 ends
In a sprawling news conference at the G-7 summit in France, the president touted the economic benefits of the ceasefire and threatened force if it fails.
iOS 27 makes your iPhone faster in 40+ ways, here’s the full list
While Apple Intelligence and Siri AI are the biggest additions to iOS 27, the update will also make your iPhone...
Siri AI may have confirmed a major iPhone 18 design change
Apple may have hidden a crucial iPhone 18 design detail in plain sight.
Siri AI hints at new iPhone 18 Pro design change
Siri AI is available in the iOS 27 beta, featuring a not-so-subtle hint about a design change that’s rumored for this fall’s iPhone 18 Pro.
The enduring legacy of 'Sirius,' the Chicago Bulls' entrance anthem
Thirty years after Chicago's historic run, the story of "Sirius" is also the story of how music helped build one of the most iconic brands in sports.
4 ways cities can become more marketable for business
Multinationals want to locate in cities with ample talent, venture capital, mobility infrastructure and climate resilience.
I spent 48 hours comparing Siri AI to Gemini — and Apple really impressed me
Apple’s new Siri AI finally delivers on its promise. After 48 hours of testing, here’s how it compares to Gemini.
Siri AI in iOS 27: Features, Requirements, and How It Works
The biggest change in iOS 27 is Apple's total overhaul of Siri, with Siri turning into Siri AI. Apple delivered on the features originally promised at WWDC 2024 and added new capabilities that turn Siri into a viable competitor to chatbots like Claude and ChatGPT. Siri AI is available in the iOS 27 beta, but everyone will get access this fall. Below, we walk through everything new you can expect from Siri.
Veteran Sire Social Inclusion Returns To Pennsylvania In 2027
Social Inclusion, a classic-placed runner and veteran sire, will return to Pennsylvania for the 2027 breeding season, standing at Bonner Hill Farms in Littlestown, Pa. The announcement was made Monday via the Pennsylvania Horse Breeders Association's social media accounts. The 15-year-old son of ...
Apple explains why Siri’s major iOS 27 overhaul took so long
iOS 27’s new Siri AI is a huge upgrade from the old Siri, but it also took longer than expected to arrive. Here’s why, per Mike Rockwell.
Roy Hattersley, former Labour deputy leader, dies aged 93
Sir Keir Starmer said Lord Hattersley "was a giant of the Labour movement".
Why Apple built a third-party AI system for Siri and then refused to show it at WWDC
Apple's iOS 27 beta contains an Extensions framework for Claude, Gemini, and ChatGPT inside Siri, but the feature was absent from the WWDC 2026 keynote.
Apple's big Siri update is here. Now the real challenge begins
Siri is finally getting the big AI upgrade Wall Street has been waiting for. But it's just the beginning.
Apple’s New Siri Is Just Good Enough to Ease Its AI Crisis
The company prepares for the foldable iPhone and touch-screen MacBook.
iOS 27 adds an all-new app to your iPhone’s Home Screen
Apple announced iOS 27 at WWDC this week, coming with a ton of new Siri and Apple Intelligence features. One...
Apple’s big Siri update is here. Now the real challenge begins
Siri is finally getting the big AI upgrade Wall Street has been waiting for. But it’s just the beginning.
From Olivia Rodrigo to The Fall of Sir Douglas Weatherford: your complete entertainment guide to the week ahead
The multiple Grammy-winner muses tunefully on love’s ups and downs, while Peter Mullan stars as a local historian in a new comedy drama
Notion Is Migrating to SwiftUI, Apple Confirms at WWDC
Apple this week confirmed that Notion is migrating its user interface to SwiftUI, citing the app's desire for greater performance and UI consistency than its existing web-based stack can deliver. Notion is a productivity app that combines notes, documents, databases, and project management tools in one place. Users can create pages containing text, tables, kanban boards, calendars, and more, and organize them in a flexible hierarchy.
Apple to Release These 15 New Products Later This Year
Apple's annual WWDC developers conference is drawing to a close, but there is still a lot to look forward to in the second half of the year. Apple is expected to release at least 15 more products later this year. Now that the more intelligent and personal version of Siri has finally arrived in beta, a full two years after Apple first previewed it at WWDC 2024, we should begin to see some new devices that were reportedly postponed until the new Siri was ready.
Siri AI is coming to newer Apple devices only, here’s the full list
Here’s the full list of Siri AI-compatible hardware across iPhone, iPad, Mac, Apple Watch, and Apple Vision Pro.
Apple Says Siri AI Won't Suck Up To You
In an interview, Apple’s SVP of engineering explains how the new Siri wasn’t designed to be sycophantic.
Apple’s Camera Chief Thinks AI Can Give You Superpowers
The generative features in iOS 27’s new Photos app will add fake pixels to some of your shots, but Apple’s Jon McCormack says the company isn’t using AI “for the sake of AI.”
Apple's Craig Federighi: Siri Won't Be Your AI Girlfriend
Apple software engineering chief Craig Federighi and marketing chief Greg Joswiak sat down for an interview with Mostly Human after during WWDC, discussing the iOS 27 Siri changes, Apple's take on AI, new child safety protections, and more. Apple set out to deliver an AI utility, not an AI companion. When asked whether users could create an AI boyfriend or girlfriend with the new Siri, Federighi said absolutely not.
iOS 27 brings another very welcome improvement to Camera Control on iPhone
iOS 27 and Siri AI introduce a positive change to the iPhone’s Camera Control. This welcome improvement is a benefit...
I'm glad Apple isn't hyping up agentic AI (yet)
Apple is more focused on delivering usable features with Siri AI, instead of hyping up agentic AI. That's a good thing.
AirPods Pro 3 drop to their best price ever as Apple announces new iOS 27 features
While we are still slightly under a couple weeks out from Amazon’s massive summer sale event, the best Prime Day...
Bypass Siri AI Waitlist on macOS 27 Golden Gate Beta: Here's How
If you installed the macOS 27 Golden Gate developer beta and have signed up to the Siri AI waitlist but are still waiting to be accepted, there's a Terminal command workaround that enables the new virtual assistant on your Mac immediately. If you're still reading, since you're on the first macOS 27 developer beta, we're assuming you are running it on a test machine, and not on your primary Mac. We're also assuming you're comfortable with using the Terminal app.
iOS 27 just broke 15 years of muscle memory on iPhone and iPad
Since iOS 5 in 2011, the iPhone and iPad have included Notification Center, a central place to find alerts from...
Jim Irons, Former Landsat Project Scientist, Wins Pecora Award
Landsat’s Jim Irons won the prestigious William T. Pecora Award. Irons, now an emeritus scientist at NASA Goddard Space Flight Center, played an integral role in shaping the Landsat program into what it is today.
I’m relieved Siri AI isn’t trying to be a health coach
I’d rather no announcement than an underbaked Siri-flavored health coach.
Craig Federighi Explains Why Apple Pivoted to a Siri Chatbot App
Apple senior vice president of software engineering Craig Federighi has explained why the company launched a standalone Siri app in iOS 27, after previously characterizing a dedicated chatbot as contrary to its Apple Intelligence strategy. The new Siri app, announced at WWDC earlier this week, gives users a centralized place to manage and revisit their conversations with Siri AI.
Apple Struck the Right Notes With Its New AI Tools. Here's 4 Features I'm Excited to Try
Siri AI is the headline feature of WWDC 26, but there are more new capabilities I need to check out.
New OMB rule could break science in the United States
The drug that saved your mother. The treatment your doctor recommended. The clinical trial that bought someone you love more time. None of it was inevitable. It required a system built to operate outside politics and sustained over decades, because science doesn’t operate on the timeline of a politician. That system is now under direct threat. The Office of Management and Budget (OMB) has proposed a new rule to regulate all federal grants, not just science, but housing, education, defense, NASA and everything in between, that would fundamentally change how research is conducted in the United States. There have been a lot of fires in the past 16 months, and if everything is an emergency, nothing is an emergency. But this is a very big deal. These rules would strip away the independence that has kept science from becoming a political tool. The good news is there’s still something we can all do. How the grant system was designed to work When I was a new faculty member, I was full of millions of ideas, so I sat down and wrote an NIH proposal. I worked on it for months and thought it was so good. Then I sent it to my mentor. It came back covered in comments. Places where my reasoning wasn’t as airtight as I’d thought, methods that could be stronger, gaps in my thinking that I had been too close to the work to see. It stung, as honest feedback always does, but peer review almost always makes the work better. In fact, it’s the backbone of how American science has functioned for generations. At NIH, submitted proposals go to a panel of scientists who have experience in the field. These are the people who can read research methods and spot their weaknesses, who understand when an experiment is designed well and when it isn’t. Applications are scored rigorously, and often only the top 3-20% of proposals receive funding. The people making funding decisions are required to justify them based on these reviews. To be clear: this is not a perfect system, and good science still goes unfunded more often than any of us would like due to limited resources. There is also criticism that peer review may undervalue bold ideas that are risky but could have high payoffs. But the peer review system is nonetheless a meaningful part of the grant selection process. While thoughtful and careful changes could improve the system, the changes being proposed by OMB will not make things better. The rule that could change everything Through this OMB proposal, the system that helps decide what gets funded is being dismantled. There are many troubling elements buried in this proposal, but three provisions stand out in particular. Each would be damaging alone. Together, they would change what kind of science gets done in America, and who it serves. 1. Political appointees would decide which science gets funded, and peer review would be explicitly sidelined or ignored. The guidelines your doctor follows, the standards that determine what’s in your air and water, the drugs that get approved for your family: all of it starts with a funding decision. Right now, that decision is made by scientists who can evaluate whether the work is actually sound and whether it could move the needle forward. Under this proposal, funding decisions could be made by political appointees. The careful, expertise-driven review process that shapes grant funding would be effectively sidelined. That means that a poorly designed study could get funded simply because someone in a political office liked the sound of it, while rigorous, important work doesn’t get funded because it no longer aligns with the administration’s priorities. In other words, critical work that benefits all of us could now be missed just because it has become politically inconvenient. 2. Grants could be canceled at any point, without warning, in the middle of ongoing work. Say your tax dollars have been paying for a cancer study for two years. The grant was awarded for five years, so the team is mid-experiment. There are three additional years’ worth of answers that could change how the disease is treated for hundreds of thousands of people. With this new rule, the federal government could cancel the remaining funding tomorrow, walk away from the commitment it made with your money, and have no legal obligation to finish what it started. This is a huge waste of money. There are rarely other sources of funding for this work, which means the team, the graduate students, postdocs, and research staff who have dedicated years of their careers to this project could lose their jobs. Patients who have contributed their time to studies may not see it turn into useful learnings for others. Every hour of work already completed could result in nothing useful. Science can take decades to get to tangible outcomes. It needs a stable funding system to flourish. 3. Researchers would have a harder time communicating their findings without pre-approval from the federal government. There is a saying from Sir Mark Walport: “Science isn’t finished until it’s communicated.” Science is no use to anyone if it is kept locked away in the labs that produced the data. The proposed rule could make communicating research findings harder in a number of ways: Make it harder for scientists to widely share their findings in scientific journals. Publication costs, including journal fees that allow for broad public access, could not be paid for by federal funds which is often how scientists pay these costs. Restrict researchers from engaging publicly about how their findings should inform policy or public health guidelines. This would restrict scientists from doing the work that transforms years of lab work into decisions that actually affect people’s lives. Make it harder for scientists to attend conferences. Conferences would now need to be approved by the federal agency at the time of grant award. This disadvantages conferences or publications that are not politically aligned. Conferences are a key way in which scientists learn about work happening in their field so they can collaborate and build on each other’s findings. What good is science with a muzzle? The long-term impact These changes could (and hopefully would) be reversed under the next administration. But by then, damage has been done. Once projects are halted or denied funding by political appointees, people leave their science careers for other paths or even leave the country to do their amazing science elsewhere. You cannot pause a scientific study the way you pause a subscription you decided isn’t useful anymore. You cannot freeze a research team that depends on salaries to feed their families, causing a scramble for replacement funding that, in most cases, simply does not exist. When the money stops, everything stops, and all the work in progress and its potential are lost. Despite all of the language about reducing waste, fraud, and abuse, this new proposed rule increases the administrative burden tremendously. Every researcher watching this unfold will make a rational decision: don’t start anything that will take a decade to finish. This includes not building a team around funding that could vanish, or asking the big questions that need patience and stability to answer. The most consequential science, the kind that produces the treatments and the breakthroughs that reach your doctor’s office twenty years from now, is exactly the science that would be abandoned first. This is still a proposal, so we can all do something Some worry this rule is already a done deal. But by law, OMB is required to open a public comment period. Those comments matter because they inform members of Congress, they can be used in litigation, and they create a public record. So here’s what you can do: Submit a public comment. The public comment period on this proposed change is open until July 13. Anyone can submit a comment, and OMB is required to respond to substantial ones. Each comment must be different to count as distinct; identical comments will be counted only once. Comment as an individual, not on behalf of your organization. Here’s a full resource to help you, with useful examples, but in general: Share a story about how science or federal funding has benefitted you or is involved in your work. Are you or someone you loved a cancer survivor? Do you know someone with Alzheimer’s? Have you received NIH/NSF or other federal funding? All of these can be stories you use to highlight why you care. Explain why you’re worried about these proposed changes. You can use the wording found here or in other resources to help you. Ask them to withdraw this proposed rule. Contact your elected representatives. Congress allocates money to federal agencies to spend, and it has oversight of how that process works. You can let your representatives know this proposed change concerns you and ask them to intervene. There are levers they can push that can help at this moment. Let others know why federal funding matters. This isn’t just about science, but ALL federal grants, including for education systems, defense projects, and more. The process, including the importance of federal funding, is invisible to many. We can all make it more visible by sharing how science benefits us and why we value it. You can also share this article, or any of the resources linked here, to help spread awareness! Bottom line We are quickly losing ground in scientific research in the U.S. More changes, like the proposed rule by OMB, would decimate our ability to conduct research here, leaving us all worse off: fewer treatments for pancreatic cancer, less research on pollution impacts, fewer answers for patients with rare disease, and more unaddressed health needs. The impact will be very real for all of us, regardless of where we stand politically. Using our voices for science is more important than ever. Love, LM Big thanks to Dr. Megan Ranney for reading this over and providing brilliant insights, as always. Dr. Liz Marnik, PhD, is Executive Director of The Evidence Collective at YLE and a science communicator and immunologist working at the intersection of public trust, science, and public health. You can find her on Substack, LinkedIn, Instagram and Threads. Your Local Epidemiologist (YLE) comprises a team of experts, ranging from physicians to immunologists to epidemiologists to nutritionists, working together with one goal: to “Translate” ever-evolving public health science so that people are well-equipped to make evidence-based decisions. The YLE suite of newsletters reaches over 475,000 people across more than 132 countries. This newsletter is free to everyone, thanks to the generous support of fellow YLE community members. To support the effort, subscribe or upgrade below: Subscribe
iPhone 17's 8GB Limit Costs It These Two Siri AI Features in iOS 27
Apple this week revealed what its most advanced on-device AI model does, and the feature list is shorter than the hardware requirements might suggest. In its Siri AI announcement during WWDC 2026, Apple confirmed that the model powers two things: more expressive Siri voices and a major accuracy gain for systemwide dictation. Both require 12GB of unified memory.
The Top New Features in Apple’s iOS 27 and iPadOS 27
Apple took the wraps off iOS 27 at its WWDC event, and the iPhone update is chock-full of smart upgrades, with a big focus on improvements to Siri.